Table:
begin	end	state
1	16	cytoplasmic
17	36	transmembrane
37	41	non-cytoplasmic
42	59	transmembrane
60	70	cytoplasmic
71	88	transmembrane
89	99	non-cytoplasmic
100	118	transmembrane
119	124	cytoplasmic
125	144	transmembrane
145	173	non-cytoplasmic
174	192	transmembrane
193	270	cytoplasmic
271	291	transmembrane
292	296	non-cytoplasmic
297	315	transmembrane
316	339	cytoplasmic
340	356	transmembrane
357	360	non-cytoplasmic
361	382	transmembrane
383	390	cytoplasmic
391	427	transmembrane
428	446	cytoplasmic
447	479	transmembrane
480	484	non-cytoplasmic
485	503	transmembrane
504	508	cytoplasmic
509	529	transmembrane
530	532	non-cytoplasmic
533	556	transmembrane
557	566	cytoplasmic
567	588	transmembrane
589	597	non-cytoplasmic
598	621	transmembrane
622	630	cytoplasmic
631	660	transmembrane
661	661	cytoplasmic
662	674	non-cytoplasmic


Input:
>GFF84
MSESQGLHASPSEWPRALFYVALLFSIYQIVTAAFHPVSSQVLRAGHVGFLLLLVFLCYP
ARGNGKPFQPVAWLLGLAGFATFFYQWYFEADLIQRSGDMTTADMVVGLTLIVLVFEAAR
RVMGIALPIICALFLAYGLLGEYLPGDLAHRGYYLDQIVNQLSFGTEGLYGTPTYVSATY
IFLFILFGSFLEQAGMIKLFTDFAMGLFGHKLGGPAKVSVVSSALMGTITGSGVANVVTT
GQFTIPLMKRFGYRPAFAGGVEATSSMGSQIMPPVMGAVAFIMAETINVPFVEIAKAALI
PALLYFGSVFWMVHLEAKRAGLKGLPKDECPSAMAAVKERWYLLIPLVVLVWLLFSGRTP
MFAGTIGLALTAIVILGSAIILKVSNFALRIAFWIALGLLCAGFFQLGIGVIFGVIAALV
AVCWFIKGGRDTLVICLHALVEGARHAVPVGIACALVGVIIGVVSLTGVASTFAGYILAV
GENNLFLSLLLTMLTCLVLGMGIPTIPNYIITSSIAAPALLDLGVPLIVSHMFVFYFGIM
ADLTPPVALACFAAAPIAKERGLKISMWAIRIAIAGFIVPFMAVYNPALMMQGGDWGATL
YMLFKAAFAVGLWGAVFTGYLQRPMALWEKVLAFAAAASMVLAMPISDEIGFALGALFLI
QHIWRARRAEPATA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server